• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Saniona

13.34 SEK

-1.91 %

Less than 1K followers

SANION

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.91 %
-6.71 %
-18.56 %
-37.08 %
-32.35 %
+38.81 %
+128.16 %
-14.87 %
+240.62 %

Saniona is a biotechnology company focused on developing treatments for neurological and psychiatric diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Saniona was founded in 2011 and is headquartered in Denmark.

Read more
Market cap
1.84B SEK
Turnover
4.68M SEK
Revenue
434.4M
EBIT %
62.39 %
P/E
6.04
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/8
2026

Interim report Q2'26

26/11
2026

Interim report Q3'26

25/2
2027

Annual report '26

Press release6/4/2026, 6:00 AM

Saniona to Host Virtual R&D Day Focusing on SAN2668 for Severe Pediatric Epilepsies

Saniona
Press release6/4/2026, 6:00 AM

Saniona arrangerar virtuell FoU-dag med fokus på SAN2668 för svåra pediatriska epilepsier

Saniona
Press release5/28/2026, 4:36 PM

Redeye: Saniona (Q1 Review): Setting up for the long run

Saniona

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/27/2026, 3:15 PM

Kommuniké från årsstämma den 27 maj 2026 i Saniona AB

Saniona
Regulatory press release5/27/2026, 3:15 PM

Bulletin from the Saniona AB annual shareholders’ meeting on May 27, 2026

Saniona
Regulatory press release5/26/2026, 6:00 AM

Saniona publicerar delårsrapport för det första kvartalet 2026

Saniona
Regulatory press release5/26/2026, 6:00 AM

Saniona publishes its interim report for the first quarter of 2026

Saniona
Press release5/20/2026, 6:00 AM

Invitation to Saniona Q1 investor call on 26 May 2026

Saniona
Press release5/20/2026, 6:00 AM

Inbjudan till Sanionas investerarsamtal för Q1 den 26 maj 2026

Saniona
Regulatory press release4/30/2026, 11:05 AM

Saniona publishes its Annual Report for 2025

Saniona
Regulatory press release4/30/2026, 11:05 AM

Saniona publicerar årsredovisningen för 2025

Saniona
Regulatory press release4/24/2026, 3:35 PM

Notice of Saniona AB annual shareholders’ meeting

Saniona
Regulatory press release4/24/2026, 3:35 PM

Kallelse till årsstämma i Saniona AB

Saniona
Interview with Saniona's CEO during SCF's 17th Capital Markets Day Life Science4:58
Video3/19/2026, 7:09 AM by
Isa Hudd

Interview with Saniona's CEO during SCF's 17th Capital Markets Day Life Science

Saniona presented at Stockholm Corporate Finance's 17th Capital Markets Days Life Science 2026. We interviewed CEO Thomas Feldthus.

Saniona
Saniona, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026
Webcast3/18/2026, 10:30 AM

Saniona, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026

Saniona
Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars
Webcast3/18/2026, 7:00 AM

Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars

Välkommen att lyssna på Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars.

Miris HoldingDevyser DiagnosticsOrtomaNextCell PharmaSaniona
Press release3/12/2026, 1:02 PM

BioStock: Saniona enters clinical execution phase following transformational year

Saniona
Press release3/12/2026, 7:00 AM

Meet Saniona at several conferences during the spring

Saniona
Press release3/12/2026, 7:00 AM

Möt Saniona på flera konferenser under våren

Saniona
Press release3/3/2026, 9:47 AM

Redeye: Saniona (Q4 review): Moving forward nicely

Saniona